TAVANIC 500 mg, comprimé pelliculé sécable — plaquette(s) thermoformée(s) PVC-aluminium de 5 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400934965562 -
CIP7
3496556 -
CIS
64784789
What the source publishes
- Holder
- SANOFI WINTHROP INDUSTRIE
- Active ingredients
- LÉVOFLOXACINE HÉMIHYDRATÉE, LÉVOFLOXACINE
- Form
- comprimé pelliculé sécable
- Package
- plaquette(s) thermoformée(s) PVC-aluminium de 5 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 1998-12-30
- Prescription
- Prescription or restricted
Names this record is found by
- TAVANIC 500 mg, comprimé pelliculé sécable — plaquette(s) thermoformée(s) PVC-aluminium de 5 comprimé(s)
- TAVANIC 500 mg, comprimé pelliculé sécable
- LÉVOFLOXACINE HÉMIHYDRATÉE
- LÉVOFLOXACINE
Complete source data
{
"cis": "64784789",
"cip7": "3496556",
"form": "comprimé pelliculé sécable",
"name": "TAVANIC 500 mg, comprimé pelliculé sécable — plaquette(s) thermoformée(s) PVC-aluminium de 5 comprimé(s)",
"cip13": "3400934965562",
"holder": "SANOFI WINTHROP INDUSTRIE",
"routes": [
"orale"
],
"holders": [
"SANOFI WINTHROP INDUSTRIE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "10.64",
"authorisedOn": "1998-12-30",
"compositions": [
{
"name": "LÉVOFLOXACINE HÉMIHYDRATÉE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "60077",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
},
{
"name": "LÉVOFLOXACINE",
"nature": "FT",
"strength": "500 mg",
"linkageNumber": "1",
"substanceCode": "81234",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "9.62",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "TAVANIC 500 mg, comprimé pelliculé sécable",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) thermoformée(s) PVC-aluminium de 5 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65%"
],
"marketingDeclaredOn": "2000-09-09",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"LÉVOFLOXACINE HÉMIHYDRATÉE",
"LÉVOFLOXACINE"
],
"authorisationProcedure": "Procédure de reconnaissance mutuelle",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- sinusites aiguës, <br>- bronchites chroniques aggravées, <br>- pneumonies dans les milieux collectifs<br>- inflammations infectieuses de la prostate <br>- pyélonéphrites aiguës (infection rénale grave) <br>- maladie du charbon (pour sa prévention). ; JOURNAL OFFICIEL ; 17/06/11",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400934965562"